Not Yet RecruitingN/AOther

Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2

Sponsored by University Hospital, Clermont-Ferrand

NCT ID
NCT07235514
Target Enrollment
958 participants
Start Date
2025-12-01
Est. Completion
2029-03-01

About This Study

The goal of this clinical trial is to learn what is the best anesthetic management in participants with severe stroke that require a medical intervention called mechanical thrombectomy (MT) done to open the occluded brain vessel. The main question it aims to answer is: • Is general anesthesia (GA) better than procedural sedation (PS) for improving functional performance and decrease dependance in daily life 3 months after stroke? GA (a non-arousable state induced by anesthetic medications that require respiratory assistance) or PS (a state of reduced arousal induced by lesser dose of anesthetic medications that do not require respiratory assistance) are both used for MT. GA enables strict immobility that could facilitate the conduct of MT but lessen blood pressure and blood flow in the brain. PS provides less drop in blood pressure but MT could be more difficult due to possible movement and breathing may be decreased. Researchers will compare GA with PS to see which one is better for MT success and for the functional consequences of stroke. Participants will be treated with GA or PS for the intervention of MT and will be followed by researchers during their hospital stay and asked by a telephone interview how is their functional status 3 months after stroke.

Conditions Studied

Ischemic StrokeAnterior Cerebral CirculationGeneral AnesthesiaProcedural SedationThrombectomy

Interventions

  • General Anesthesia
  • Procedural sedation

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age ≥18 years
* Acute ischemic stroke with an occlusion of the intracranial internal carotid artery and/or the proximal middle cerebral artery (M1-M2) with or without association of extracranial occlusion of the cervical internal carotid artery (tandem lesion)
* Eligible for mechanical thrombectomy according to international guidelines
* Informed and signed consent of patient, or if he is unable to consent the consent of patient's relative or emergency procedure in the absence of relative
* National health insurance

Exclusion Criteria:

* Coma or altered vigilance defined as a score ≥ 2 on the level of consciousness 1A subscale of the NIHSS
* Premorbid disability defined as a mRS \> 2
* Posterior circulation stroke
* Associated cerebral hemorrhage
* Stroke complicating another acute illness or postoperative stroke
* Emesis at arrival in angiosuite
* Allergy to anesthetic medication
* Pregnant or breast-feeding women
* Adult under the protection of the law

Study Locations (1)

CHU de Clermont-Ferrand
Clermont-Ferrand, France

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source